BiotechTube
Home/Proniras/Andrew Chambers, MD
AC

Andrew Chambers, MD

Addiction Psychiatry PI

Proniras

Therapeutic Areas

Substance Use DisordersCentral Nervous System (CNS) Disorders

Proniras Pipeline

DrugIndicationPhase
Tezampanel (PRN-001-01)Opioid Use Disorder (Opiate Withdrawal Syndrome)Phase 1

Leadership Team at Proniras

TQ
Thong Q. Le
President & CEO
CT
Christopher Toombs, PhD, DABT
Cofounder & Chief Scientific Officer
LR
Lindsay Rayle
Vice President of Finance
View full Proniras profile